Function and structure of heterodimeric amino acid transporters

American Journal of Physiology - Cell Physiology

Volumn 281, Issue 4 50-4, 2001, Pages

  Wagner, Carsten A ^a   Lang, Florian ^b   Bröer, Stefan ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Cystinuria; Disulfide bridge; Heavy and light chains; Lysinuric protein intolerance

Indexed keywords

AMINO ACID TRANSPORT; CELL DIFFERENTIATION; CELL GROWTH; DISULFIDE BOND; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION;

EID: 0034796442     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.2001.281.4.c1077     Document Type: Review

References (159)

1. Mutations in the SLC3A1 gene in cystinuric patients: Frequencies and identification of a novel mutation
2. +-independent L-alanine uptake by trout cells. Evidence for the existence of at least two functionally different asc systems
3. -
4. SLC7A8, a gene mapping within the lysinuric protein intolerance critical region, encodes a new member of the glycoprotein-associated amino acid transporter family
5. +-like amino acid transport by the heavy chain of human 4F2 surface antigen in Xenopus laevis oocytes
6. Expression cloning of a human renal cDNA that induces high affinity transport of L-cystine shared with dibasic amino acids in Xenopus oocytes
7. Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids
8. Molecular analysis of the cystinuria disease gene: Identification of four new mutations, one large deletion, and one polymorphism
9. Selective expression of the large neutral amino acid transporter at the blood-brain barrier
10. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance
11. +L in erythrocytes of patients with lysinuric protein intolerance
12. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells
13. The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux
14. +LAT2 requires different domains
15. Discrimination of two amino acid transport activities in 4F2 heavy chain-expressing Xenopus laevis oocytes
16. +LAT2 mediates arginine efflux in exchange with glutamine
17. + exchange and a substrate-gated anion conductance
18. Molecular identification of astroglial neutral amino acid transport systems
19. The 4F2hc surface antigen is necessary for expression of system L-like neutral amino acid-transport activity in C6-BU-1 rat glioma cells: Evidence from expression studies in Xenopus laevis oocytes
20. Expression of the surface antigen 4F2hc affects system L-like neutral-amino-acid-transport activity in mammalian cells
21. Early effects of aldosterone on the basolateral potassium conductance of A6 cells
22. Opposite directed currents induced by the transport of dibasic and neutral amino acids in Xenopus oocytes expressing the protein rBAT
23. Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine
24. TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells. Loss of response in tumor cells
25. Identification of an amino acid transporter associated with the cystinuria-related type II membrane glycoprotein
26. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by α3β1 integrin and regulated by insulin-like growth factor-1 and CD98
27. +L-like. A tertiary active transport mechanism for renal reabsorption of cystine and dibasic amino acids
28. An intracellular trafficking defect in type I cystinuria rBAT mutants M467T and M467K
29. Role of amino acid transport and countertransport in nutrition and metabolism
30. Gene-product designations for amino acid transporters
31. Electrogenic amino acid exchange via the rBAT transporter
32. Dating the origin of the V170M mutation causing non-type I cystinuria in Libyan Jews by linkage disequilibrium and physical mapping of the SLC7A9 gene
33. +L in cultured human fibroblasts: Normal phenotype of cells from LPI subjects
34. Progressive C-terminal deletions of the renal cystine transporter, NBAT, reveal a novel bimodal pattern of functional expression
35. Phenotype characterization and prevalence of rBAT M467T mutation in Italian cystinuric patients
36. Lysine fluxes across the jejunal epithelium in lysinuric protein intolerance
37. Surface antigen CD98(4F2): Not a single membrane protein, but a family of proteins with multiple functions
38. Transporters for cationic amino acids in animal cells: Discovery, structure, and function
39. +L) in human erythrocytes that recognizes lysine and leucine with high affinity
40. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance
41. Identification of five novel SLC3A1 (rBAT) gene mutations in Japanese cystinuria
42. Membrane potential dependence of the kinetics of cationic amino acid transport systems in human placenta
43. Glycine transport in human erythrocytes
44. Genomic organization of a human cystine transporter gene (SLC3A1) and identification of novel mutations causing cystinuria
45. +L/4F2hc is a heteromultimeric complex
46. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel
47. o,+ AT) of rBAT
48. Complementation of dominant suppression implicates CD98 in integrin activation
49. Distinct domains of CD98hc regulate integrins and amino acid transport
50. Functional analysis of mutations in SLC7A9, and genotype-phenotype correlation in non-type I cystinuria
51. Transport interactions of cystine and dibasic amino acids in isolated rat renal tubules
52. +-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids
53. Identification of two leucine-sensitive lysine transport activities in human placental basal membrane
54. rBAT, related to L-cysteine transport, is localized to the microvilli of proximal straight tubules, and its expression is regulated in kidney by development
55. L-serine and glycine serve as major astroglia-derived trophic factors for cerebellar purkinje neurons
56. Molecular genetics of cystinuria: Identification of four new mutations and seven polymorphisms, and evidence for genetic heterogeneity
57. Identification of two novel mutations [P122S (364C>T) and 1601delAC] in the SLC3A1 gene in type I cystinurics
58. 335-Base deletion in the mRNA coding for a dibasic amino acid transporter-like protein (SLC3A1) isolated from a patient with cystinuria
59. Mutations in the genomic deoxyribonucleic acid for SLC3A1 in patients with cystinuria
60. Cystinuria subtype and the risk of nephrolithiasis
61. Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98
62. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes
63. Molecular genetics of cystinuria in French Canadians: Identification of four novel mutations in type I patients
64. Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation
65. Inductlon of cystine transport activity by stress
66. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier
67. +L neutral and basic amino acid transporter. Insights into the mechanisms of substrate recognition
68. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)
69. Expression of mRNA (D2) encoding a protein involved in amino acid transport in S3 proximal tubule
70. A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect
71. Heterodimeric amino acid transporters: Expression of heavy but not light chains of CD98 correlates with induction of amino acid transport systems in human placental trophoblast
72. The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants
73. Characterisation of L-tryptophan transporters in human placenta: A comparison of brush border and basal membrane vesicles
74. Cloning and chromosomal localization of a human kidney cDNA involved in cystine, dibasic, and neutral amino acid transport
75. B and T cell immunity in patients with lysinuric protein intolerance
76. Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2
77. + amino acid transport activities in Xenopus laevis oocytes
78. The light chain of CD98 is identified as E16/TA1 protein
79. o,+-related amino acid transport
80. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family
81. Cystine uptake by rat renal brush-border vesicles
82. +L as the high-affinity transporter for L-arginine in human platelets: Up-regulation of L-arginine influx in uraemia
83. Mutations of the basic amino acid transporter gene associated with cystinuria
84. +-independent neutral and basic amino acid transporter on amino acid transport in Xenopus oocytes
85. o,+-like amino acid transport system in a "renal proximal tubular" cell line (OK cells)
86. Membrane topology of the rat kidney neutral and basic amino acid transporter
87. Characterization of the rat neutral and basic amino acid transporter utilizing anti-peptide antibodies
88. AG, and ASC in swine small intestine
89. +LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI)
90. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer
91. +-independent transporter for small neutral amino acids that transports D-serine with high affinity
92. Immunocytochemical localization of the renal neutral and basic amino acid transporter in rat adrenal gland, brainstem, and spinal cord
93. SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families
94. +L activity on the basal plasma membrane surface of rat placenta and developmentally regulated expression of 4F2HC mRNA
95. Paramyxovirus-induced syncytium cell formation is suppressed by a dominant negative fusion regulatory protein-1 (FRP-1)/CD98 mutated construct: An important role of FRP-1 in virus-induced cell fusion
96. Cystine uptake by rat jejunal brushborder membrane vesicles
97. Heteromeric amino acid transporters explain inherited aminoacidurias
98. Molecular biology of mammalian plasma membrane amino acid transporters
99. Cystinuria calls for heteromultimeric amino acid transporters
100. Brain metabolism: A perspective from the blood-brain barrier
101. Interactions between the thiol-group reagent N-ethylmaleimide and neutral and basic amino acid transporter-related amino acid transport
102. o,+-type amino acid transporter
103. Luminal heterodimeric amino acid transporter defective in cystinuria
104. +L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family
105. Functional heterodimeric amino acid transporters lacking cysteine residues involved in disulfide bond
106. Ultrastructural localization of a neutral and basic amino acid transporter in rat kidney and intestine
107. Regional and subcellular distribution of a neutral and basic amino acid transporter in forebrain neurons containing nitric oxide synthase
108. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids
109. Localization of a gene causing cystinuria to chromosome 2p
110. A splicing mutation (891+4A→G) in SLC3A1 leads to exon 4 skipping and causes cystinuria in a Moslem Arab family
111. Mutations in the SLC3A1 transporter gene in cystinuria
112. Human LAT1, a subunit of system L amino acid transporter: Molecular cloning and transport function
113. Detection of two novel large deletions in SLC3A1 by semi-quantitative fluorescent multiplex PCR
114. Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: A type II membrane glycoprotein involved in normal and neoplastic cell growth
115. o,+ amino acid transporter
116. +-independent, broad-specific neutral amino acid transporter from mammalian intestine
117. o,+-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria
118. Lysinuric protein intolerance. Basolateral transport defect in renal tubuli
119. Thyroid hormone transport by 4F2hc-IU12 heterodimers expressed in Xenopus oocytes
120. Cystinuria: Biochemical evidence for three genetically distinct diseases
121. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine
122. Molecular genetics of cystinuria: Mutation analysis of SLC3A1 and evidence for another gene in type I (silent) phenotype
123. Expression of E16/CD98LC/hLAT1 is responsive to 2,3,7,8-tetrachlorodibenzo-p-dioxin
124. Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages
125. - and maintenance of intracellular giutathione levels in pancreatic acinar and islet cell lines
126. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins
127. Transport of L-cystine in isolated perfused proximal straight tubules
128. Regulation of L-leucine transport in rat kidney by dexamethasone and tri-iodothyronine
129. Transport interaction of cystine and dibasic amino acids in renal brush border vesicles
130. +-independent neutral amino acid transporter with broad substrate selectivity
131. Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts
132. Transformation of BALB3T3 cells caused by over-expression of rat CD98 heavy chain (HC) requires its association with light chain: Mis-sense mutation in a cysteine residue of CD98HC eliminates its transforming activity
133. Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance
134. Characterization of early aldosterone-induced RNAs identified in A6 kidney epithelia
135. Cystine and dibasic amino acid uptake by opossum kidney cells
136. Membrane transport of neuronal nitric oxide synthase substrate L-arginine is constitutively expressed with CAT1 and 4F2hc, but not CAT2 or rBAT
137. Protein tyrosine kinase activation provides an early and obligatory signal in anti-FRP-1/CD98/4F2 monoclonal antibody induced cell fusion mediated by HIV gp160
138. +-independent neutral amino acid transporter from rat kidney
139. 2 terminus
140. Post-transcriptional regulation of the transferrin receptor and 4F2 antigen heavy chain mRNA during growth activation of spleen cells
141. +-independent lysine transport in human intestinal Caco-2 cells
142. +L. A candidate gene for lysinuric protein intolerance
143. +LAT-1, as the lysinuric protein intolerance gene
144. Mouse alloantigen Ly10 is identical to murine fusion regulatory protein-1 (mFRP-1)/4F2/CD98: Aberrant expression of mFRP-1/Ly10 allotypes in cells derived from CDF1 mice due to the gene deletion
145. Cutting edge: Primary structure of the light chain of fusion regulatory protein-1/CD98/4F2 predicts a protein with multiple transmembrane domains that is almost identical to the amino acid transporter E16
146. + independence of the latter a consequence of cell maturation?
147. Amino acid transport in developing animal oocytes and early conceptuses
148. +-independent transport of basic and zwitterionic amino acids in mouse blastocysts by a shared system and by processes which distinguish between these substrates
149. New glycoprotein-associated amino acid transporters
150. Glycoprotein-associated amino acid exchangers: Broadening the range of transport specificity
151. Hypertonicity activates nonselective cation channels in mouse cortical collecting duct cells
152. Mutual inhibition of L-cystine/L-cysteine and other neutral amino acids during tubular reabsorption. A microperfusion study in rat kidney
153. Reexamination of the interplay between dibasic amino acids and I-cystine/L-cysteine during tubular reabsorption
154. The heterodimeric amino acid transporter 4F2hc/LAT1 is associated in Xenopus oocytes with a non-selective cation channel that is regulated by the serine/threonine kinase sgkl
155. Oligomeric structure of a renal cystine transporter: Implications in cystinuria
156. +-independent neutral amino acid transport systems in primary cultures of rat hepatocytes. Time-dependent changes in activity
157. Cloning of a rat kidney cDNA that stimulates dibasic and neutral amino acid transport and has sequence similarity to glucosidases
158. The 4F2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes
159. +-independent neutral amino acid transporter cloned from rat kidney and its expression in mammalian tissues and Xenopus laevis oocytes